Does ACE inhibitor therapy delay onset and progression of cardiac dysfunction in duchenne muscular dystrophy?
Hirano
Michio
M
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D009202:Cardiomyopathies / Q000209:etiology* / Q000503:physiopathology; D002648:Child; D018450:Disease Progression; D006801:Humans; D015337:Multicenter Studies as Topic; D020388:Muscular Dystrophy, Duchenne / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D020913:Perindopril / Q000627:therapeutic use*; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000806:Angiotensin-Converting Enzyme Inhibitors; D010919:Placebos; D020913:Perindopril